Galmed Pharmaceuticals Ltd. (GLMD) Stock Price, Quote & AI Analysis

Live GLMD stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Galmed Pharmaceuticals Ltd..

TradeVae provides AI-driven analysis and real-time market intelligence for Galmed Pharmaceuticals Ltd. (GLMD), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

G
GLMD
Galmed Pharmaceuticals Ltd.
real-time
$0.00 +0.00 (+0.00%)
Market Cap
$4,945,923.42
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Nov 24, 2026 Q3
Market
EPS Estimate: $-0.3978
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Galmed Pharmaceuticals Ltd.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Galmed Pharmaceuticals Ltd. Overview

Company information

Company Overview

Company description not available

Company Details
Market Cap
$4.95M
Weighted Shares Outstanding
1,068,234
Employees
6
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Galmed Pharmaceuticals Ltd. Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...